Market closed
Alpha Tau Medical Ltd./$DRTS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.
Ticker
$DRTS
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Jerusalem, Israel
Employees
125
ISIN
IL0011839383
Website
DRTS Metrics
BasicAdvanced
$251M
-
-$0.45
0.93
-
Price and volume
Market cap
$251M
Beta
0.93
52-week high
$3.14
52-week low
$2.30
Average daily volume
34K
Financial strength
Current ratio
7.404
Quick ratio
6.909
Long term debt to equity
18.391
Total debt to equity
20.004
Interest coverage (TTM)
-118.95%
Management effectiveness
Return on assets (TTM)
-23.27%
Return on equity (TTM)
-43.16%
Valuation
Price to book
3.32
Price to tangible book (TTM)
3.32
Price to free cash flow (TTM)
-9.396
Growth
Earnings per share change (TTM)
8.04%
3-year earnings per share growth (CAGR)
-12.29%
DRTS News
AllArticlesVideos
Alpha Tau Announces Appointment of Nadav Kidron to its Board of Directors
GlobeNewsWire·4 days ago
Alpha Tau to Participate in May Investor Conferences
GlobeNewsWire·2 weeks ago
Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals
GlobeNewsWire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Alpha Tau Medical Ltd. stock?
Alpha Tau Medical Ltd. (DRTS) has a market cap of $251M as of May 17, 2025.
What is the P/E ratio for Alpha Tau Medical Ltd. stock?
The price to earnings (P/E) ratio for Alpha Tau Medical Ltd. (DRTS) stock is 0 as of May 17, 2025.
Does Alpha Tau Medical Ltd. stock pay dividends?
No, Alpha Tau Medical Ltd. (DRTS) stock does not pay dividends to its shareholders as of May 17, 2025.
When is the next Alpha Tau Medical Ltd. dividend payment date?
Alpha Tau Medical Ltd. (DRTS) stock does not pay dividends to its shareholders.
What is the beta indicator for Alpha Tau Medical Ltd.?
Alpha Tau Medical Ltd. (DRTS) has a beta rating of 0.93. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.